Introduction
Hodgkin's disease (HD) is classified as a malignant disorder of the lymphatic system [1] . In affected tissue, the characteristic Hodgkin-Reed Sternberg (H-RS) cells represent a minority of less than 1% of cells. They are surrounded by a mixture of reactive cells, predominantly activated CD4 positive T-lymphocytes [2] . Until recently, the presence of clonal H-RS cells and the clonal recurrence and dissemination of these cells in relapsing HD has not been demonstrated.
To overcome the problem of analysing small amounts of tumor cells in an admixture of various non malignant cells micromanipulation of single H-RS cells from frozen tissue sections [3] or cytospins [4] with subsequent amplification of rearranged immunoglobulin (Ig) genes has been established. This method, for the first time, allowed genotyping of single H-RS cell. Using this approach different groups have provided evidence that in the majority of cases H-RS cells represent B-lymphoid cells [3, [5] [6] [7] [8] . In a substantial proportion of these cases, sequence analysis of amplified Ig genes revealed a clonal relationship between the micromanipulated H-RS cells. In addition, somatic mutations within the rearranged Ig genes indicating the derivation of H-RS cells from germinal center cells were demonstrated [3, 8] . In HD affected lymph nodes clonal populations have also been detected by fluorescence in situ hybridisation (FISH) of centromer specific probes on interphases in combination with simultaneous determination of DNA content [9] or immunophenotyping [10] . For amplification of Ig gene rearrangements H-RS cells were micromanipulated from a restricted area of a single lymph node for a given case. It thus could not be ruled out that H-RS cell clonality reflected a locally restricted clonal proliferation just in the lymph nodes analysed. This hypothesis might be supported by reports describing the detection of oligoclonal H-RS cell populations in some cases [5] [6] [7] .
Taken together, these studies did not answer the question whether the same clonal population of H-RS cells occurred in one patient sequentially at primary diagnosis and at different sites in relapse. Recently, we detected clonal relapse in a patient with mixed cellularity Hodgkin's disease [11] . Here we describe in detail the clinical history of this patient and present the DNA sequences of the H-RS cell specific rearranged Ig genes in lymph node specimens obtained at primary diagnosis of HD and in a relapse 2.5 years later.
Case report
In 1991, a 31-year-old man presented with a swelling of a cervical lymph node. Subsequently, a lymph node biopsy was performed that revealed HD of mixed cellularity subtype. No further manifestations of the disease were detected in CT scans and bone marrow biopsy (CS IA). Since staging laparotomy was not performed a primary PS IIIA cannot be excluded. Extended field irradiation with 40 Gy resulted in a complete clinical remission. In 1992, routinely performed abdominal ultrasonic examination revealed an enlargement of a splenic hilar lymph node. Laparotomy was performed and revealed HD of the spleen and enlarged splenic hilar lymph node (PS IIIA). Biopsies of the liver and the omentum showed no involvement with HD. No post surgical therapy was given. In 1993, the patient reported fever, night sweat and loss of weight. Clinical and pathological examinations revealed a recurrence of HD involving abdominal lymph nodes and one lytic lesion of the right iliac bone with swelling of surrounding soft tissue (PS IVB). The patient was treated with three cycles of polychemotherapy with the COPP/ABVD regimen (cyclophosphamide, vincristine, procarbazine, prednisone/adriamycin, bleomycin, vinblastine, dacarbazine). Thereafter post treatment staging by CT scans of the chest and the abdomen revealed absence of all lymphatic manifestations. The lytic lesion of the iliac bone showed all signs of regression including sclerosis and total regression of the soft tissue alterations. One month after the complete clinical state of remission was documented high dose chemotherapy with CBV (cyclophosphamide, BCNU, etoposide) and autologous bone marrow transplantation (ABMT) was performed. Two months after ABMT a continuous complete remission was again documented in imaging and laboratory tests. Three months after ABMT B-symptoms occurred and relapse of the disease was diagnosed in an inguinal lymph node, in the bone marrow, the liver and the abdominal lymph nodes (PS IVB). Again, chemotherapy according to the COPP/ ABVD regimen was given, however, without significant response. In 1994, the patient was admitted to our hospital for the first time for experimental treatment with Ricin A coupled anti-CD25 immunotoxin. This treatment showed no beneficial result. Thereafter, therapy according to the Dexa BEAM protocol (dexamethasone, BCNU, etoposide, cytosin arabinoside, melphalan) was initiated, but had to be stopped after few days due to severe liver toxicity. The patient died in May 1994 with pneumonia and lymphoma progression.
Materials and methods

Methods
Cell lines
LI 236 is an EBV-negative H-RS cell line established from the peripheral blood of the patient presented in April 1994. L1236 cells are of B-cell origin and carry two rearrangements of Ig heavy chain genes (IgH) and one Ig kappa light chain gene rearrangement [12] . The DNA sequences of these Ig gene rearrangements are identical to those of Ig genes amplified after micromanipulation of H-RS cells from a bone marrow biopsy of the patient in April 1994 [13] . Thus, L1236 represents the first HD cell line with a proven H-RS cell origin. DNA from this cell line served as positive control. LI 309 is an EBV-immortalised polyclonal lymphoblastoid B-cell line (LCL) established from the peripheral blood of a healthy donor by superinfection with the EBV strain B95-8 and was used as negative control. Both cell lines were grown in suspension at 37 °C in RPMI 1640 (Gibco BRL) containing 100 U/ml penicillin and 100 ug/ml streptomycin supplemented with 10% fetal calf serum and 2 mM glutamine in an atmosphere containing 5% CO 2 .
Tissue specimens 10 um thick paraffin embedded sections from the 1991 diagnosed cervical lymph node and from the 1993 relapsed inguinal lymph node were used for PCR analysis. 10 um thick paraffin embedded lymph node sections from an unaffected individual were used as negative control.
PCR analysis
For PCR, high molecular weight DNA was extracted from the control cell lines using standard protocols [14] . DNA extraction from 10 um paraffin sections was performed according to Gall et al. [15] with modifications. The quality of DNA was assessed by amplification of the microsatellite locus HUMF13A01 [16] (data not shown). For sensitive detection of the H-RS cell specific rearranged VH1 V region gene fragment, seminested PCR was performed. An oligonucleotide hybridising within the framework region III of the L1236 rearranged VH1 gene (VH1C2: 5'CCAGAAATACGTCCACGACT3') was selected as the upstream primer in the first and second round. The downstream primer of the first round represented an oligonucletide sequence obtained from the JH-region (JH4b: 5'ACCTCAGGAGACGGTGAC-CAGGGT3'). The PCR was seminested using a clone-specific internal oligonucleotide sequence complementary to the D-J rearrangement (3H1: 5'GTGGCCATTGTAGTTCCCAC3'). PCR reactions were carried out in a 50-ul volume containing 50 mM KG, 2 5 mM MgCl 2 , 0.2 mM dNTPs, 25 pmol of each primer and one Unit Taq DNA polymerase (Promega, Heidelberg, Germany). For the first round of PCR 30 cycles of denaturation at 95 = C for 60 seconds, annealing at 58 = C for 60 seconds, and extension at 72 = C for 90 seconds were performed in a Triothermoblock (Biometra, Gottingen, Germany). The second round consisted of 35 cycles under the same conditions using 2 ul of first round as template. PCR products were separated on a 1.5% agarose gel. extracted using a gel extraction kit (Qiagen, Hilden. Germany) and directly sequenced on both strands (cycle sequencing kit. Gibco BRL. Eggenstein. Germany).
Results
The genomic sequence of the VH1 Ig gene rearrangement present in the patients H-RS cells had been analysed in H-RS cells isolated from bone marrow in April 1994 [13] . The sequence was found to be identical to that found in the cell line LI236 established from the periph- eral blood of this patient [12] . Based on this sequence information we analysed biopsy specimens from the cervical lymph node taken at the first diagnosis in 1991 and from an inguinal lymph node excised during the relapse in December 1993. DNA was extracted and a seminested PCR was performed. In independent experiments, a 119 base pair fragment specific for the rearranged VH1 gene in the H-RS cells was amplified from both tissue specimens as well as from the positive control L1236 (Figures 1 and 2 ). By comparison of the obtained sequences with the known sequences specific for the VH1 rearrangement in the patients H-RS cells, the identical sequence was detected in both lymphoma specimens including the known pattern of somatic mutations ( Figure 3 ). These findings demonstrate the persistence of the same clonal cell population in lymphoma tissue at primary diagnosis and in the lymph node biopsy obtained during relapse of HD 2.5 years later.
Discussion
Since the first description of Hodgkin's disease by T. Hodgkin in 1832 [17] the malignant nature of H-RS cells has been a matter of debate. Even using micromanipulation of single cells and amplification of immunoglobulin genes, clonality of H-RS cells has only been demonstrated in lymph node sections at a given time point, not, however, during subsequent states of the disease. Recently, Delecluse et al. [18] found no Ig gene rearrangement in micromanipulated H-RS cells obtained from lymph node sections in primary diagnosis and relapse of a five-year-old boy with HD of the nodular sclerosis subtype. This negative result was most probably due to DNA degradation during formalin fixation. Davis et al. [19] reported detection of an identical TCR gene rearrangement in lesions of a patient presenting with a lymphomatoid papulosis in 1971, HD in 1975 and cutaneous T-cell lymphoma in 1985. This TCR rearrangement, however, could not be attributed to the H-RS cells in situ and might have been derived from the T-cell lymphoma.
In several studies the detection of clonal EBV by hybridising a molecular probe for the virus terminal repeat region [20] on DNA extracted from different affected lymph nodes has been used to demonstrate the clonal evolution of H-RS cells [21] [22] [23] . However, by the same method clonal EBV genomes have been likewise detected in hyperplastic lymphoid tissue [24] . Since evidence was obtained that B-cells surrounding the H-RS cell can be infected by EBV [25, 26] it could not be proven that the detection of clonal EBV in HD derived lymph nodes reflected the EBV population which infected the H-RS cells.
Using fluorescence in situ hybridisation of a satellite DNA probes on interphases Inghirami et al. [9] demonstrated an unique pattern of distinct chromosomal gains and losses in H-RS cell populations obtained from multiple biopsies of the same patient and therefore suggested a clonal relationship between these H-RS cell populations. H-RS cells were detected by morphological characterisation in interphase nuclei and not by simultaneously immunophenotyping of H-RS cells in situ. Thus, the H-RS cell derivation of the analysed interphases obtained from the heterogeneous tissue samples could not be unequivocally demonstrated. In addition, since not all H-RS cells contained the same number of each chromosome, the existence of oligoclonal H-RS cell populations formally could not be ruled out.
In summary, in the studies mentioned above neither the repeated detection of a T cell receptor rearrangement nor the detection of clonal EBV or of clonally related chromosomal aberrations could be unequivocally attributed to H-RS cells. In contrast, the rearranged Ig gene sequence used in our study has been identified in the H-RS cells present in the patients bone marrow via micromanipulation and single cell PCR [13] . This amplified DNA fragment thus represents a genetic marker for specific detection of clonally related H-RS cells in tissue specimens from one patient obtained at different stages of disease.
In the presented patient we describe the occurrence of an identical H-RS cell specific rearranged Ig gene fragment in a cervical lymph node at first diagnosis of clinical stage IA HD and in an inguinal lymph node 2.5 years later in relapsed clinical stage IVB HD. This finding indicates the evolution of a clonal H-RS cell population during the primary localised manifestation of HD and persistence and dissemination of this clone despite aggressive treatment including high dose chemotherapy and autologous bone marrow transplantation to maintain complete clinical remission. Thus, in this case the true malignant nature of H-RS cells defined by dissemination and recurrence of the identical H-RS cell clone in relapsing disease has been demonstrated.
